Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
2 0WAY S TO I M P R O V E PAT I E N T C A R E & P H A R M A C Y C O S T C O N TA I N M E N T PharMEDium – Compounding by 503B Registered Outsourcing Facilities PharMEDium is the national leader in customized pharmacy sterile compounding for hospital intravenous and epidural therapies. PharMEDium has been committed to developing quality processes that facilitate the highest level of safety. Founded:2003 Toll-free Phone: (800) 523-7749 Fax: (847) 234-1363 Address:150 North Field Drive, Suite 350 Lake Forest, IL 60045 Website:www.pharmedium.com Company Background PharMEDium is the nation’s leading provider of pharmacyoutsourced, ready-to-use sterile compounded preparations. PharMEDium helps to: mitigate medication supply issues, enhance patient safety efforts, reduce drug waste, and simplify regulatory compliance. Our commitment to advancing patient safety is embodied through enhanced labeling, packaging, and bar code scanning technology designed to help reduce the potential for medication errors. As a trusted partner, PharMEDium reliably and consistently works to meet our customers’ need for customized, ready-to-use admixtures for critical medication therapies. PharMEDium, a part of AmerisourceBergen, serves over 3,000 acute care hospitals and ambulatory surgery centers through its four state-of-the-art FDA Registered 503B Outsourcing Facilities, which are also licensed as applicable by the States. Compounding centers processing controlled substances are registered with the U.S. DEA. At PharMEDium, highly trained and qualified personnel adhere to rigorous quality standards and applicable cGMPs using only FDA-approved sterile drugs and FDA-cleared sterile containers to prepare our products. We monitor the process to detect and eliminate variances, all of which allows us to achieve high-quality, safe compounded sterile preparations. PharMEDium helps meet the demands placed on hospitals and surgery centers to ensure that patients receive their medications on time and as prescribed. PharMEDium provides a broad portfolio of medications used for pain management, operating room anesthesia, intensive care, nerve block, and labor and delivery to hospital pharmacies and surgery centers as an extension of their sterile I.V. and epidural programs. PharMEDium’s robust supply chain, redundant centers, and strict allocation process help us to provide for superior continuity of service during drug shortages, natural disasters, or local disruptions. Customer Support As a PharMEDium customer, you not only deserve the highest level of quality, you deserve the highest level of service. That’s why we assign a team of professionals to ensure each customer receives the same high level of support and that it continues in effect over the course of our relationship. Your team will supply what you need — from the emergency room to the operating room to the patient’s room. Our team is here to provide: • 24/7 Customer Support • Evaluation of Drug Usage and Waste • Clinical In-Service Resources • Medication Tray Standardization and Configuration • Answers to Clinical Inquiries and Documentation Requests • GPO/IDN Contract Support Ordering Information With multiple ways to purchase, including Electronic DEA Form 222 controlled substance ordering system (CSOS), getting compounded admixture services from PharMEDium is simple and easy. To learn more, please call PharMEDium customer service at (800) 523-7749 or visit www.pharmedium.com. Product Overview PharMEDium is committed to patient safety. Our approach to developing state-of-the-art compounded sterile preparations involves a complete analysis of the medication use process and hospital pharmacy requirements. We invest in understanding all aspects of drug therapies, drug dispensing, and emerging technologies to deliver solutions that reduce the potential for mediation errors and the associated costs. SUMMER 2016 I H E A LT H S Y S T E M • I N F U S I O N 43